Somatic mutations in JAK2 and other epigenetic regulators, such as TET2 and ASXL1, prevalent in myeloid cancers, such as PV, induce proinflammatory conditions in monocytes and macrophages [25, 32, 33]. The gene discussed is JAK2; the disease is acquired polycythemia vera.